| Trial ID: | L0856 |
| Source ID: | NCT02647294
|
| Associated Drug: |
Maxicor
|
| Title: |
Nutrition-based Therapy of Liver Disease of Different Origin: Effect of n-3 Polyunsaturated Fatty Acid in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome.
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD
|
| Interventions: |
Dietary Supplement: Maxicor;Other: Placebo
|
| Outcome Measures: |
Number of patients with decreased liver fat content.Number of patients with progression of liver fibrosis.
|
| Sponsor/Collaborators: |
General University Hospital, Prague
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Not applicable
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
04/01/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Czechia;Czech Republic
|
| URL: |
https://clinicaltrials.gov/show/NCT02647294
|
